Home | School Profile | Administration | Library | Student Affairs | Academic Affairs | Academic Programs |
Research Training
| Alumni | Outpatient Clinics | Contact Us

Research Training

Web Mail System
Faculty and Research




Iván Vidal Foundation




Scientific Projects (2008-2009)

Dr. Wilfredo Hernandez
Title: Suppression of Mutagenesis with Antioxidants

Preventive medicine is the rational response to the rising medical costs. This response includes a renewed emphasis on antioxidant foods and supplements to lower risk from cancer, which is now the number one fatal disease. Current theories of cancer highlight hypoxia in microenvironments where oxidative stress damages DNA and promotes mutagenesis. Our major aim is to evaluate suppression of mutagenesis by sulfhydryl antioxidants N-acetylcysteine (NAC), and alpha-lipoic acid, both of which potentiate glutathione activity, the gold standard of antioxidants. Vitamin C will be used as a standard. Surprisingly, few antioxidant studies have addressed directly the suppression of mutagenesis. Most rely on end points of survival times, anticarcinogenic activity, or chromosomal damage. We hypothesize that the sulfhydryl antioxidants will prevent mutations induced by hydrogen peroxide and gamma radiation, treatments that mimic endogenous mutagenesis by OH radicals. Mutation frequencies (mf) will be quantitated by measuring mutations in a LacI repressor gene, contained in the chromosome of live transgenic Big Blue mice and its cultured cells. Mutations will be detected because the damaged LacI will not be able to repress the expression of the reporter gene (b-galactosidase) in a bacterial system, rendering the resulting plaque blue. These mf will be compared with those obtained by quantification of 8-oxo-guanine production. Suppression of mutations by antioxidants in live Big Blue mice subjected to gamma radiation will be evaluated by two methods: LacI gene mutations and 8-oxo-guanine production. This work will test the notion that antioxidants can effectively block mutations caused by oxidative damage. In addition, our results will provide a basis for a rational policy on the use of antioxidant supplements in humans, either as an anticancer strategy or for counteracting age-related diseases.